aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript

Page 4 of 4

Really nice how you’re thinking about that. And it’s already things that– experts are noodling over, potentially to do something outside of the trial.

Operator: Thank you. I would now like to turn the call back over to Sanjay for any closing remarks.

Sanjay Shukla: Great. Well, we thank everybody’s interest. Great questions today. I know there’s a lot of expectation of everyone’s really looking forward to getting this trial wrapped up here we are too. Appreciate everyone’s interest here. Thank you for following us and look forward to talking to you in the future. Thanks again.

Operator: Thank you for your participation. You may now disconnect.

Follow Life Technologies Corp (NASDAQ:LIFE)

Page 4 of 4